Tori N. Yamamoto
Gladstone Institutes(US)University of California, San Francisco(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Virus-based gene therapy research
Most-Cited Works
- → Identification of essential genes for cancer immunotherapy(2017)885 cited
- → Ionic immune suppression within the tumour microenvironment limits T cell effector function(2016)663 cited
- → T cell stemness and dysfunction in tumors are triggered by a common mechanism(2019)518 cited
- → CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor(2013)311 cited
- → Evaluation of SARS-CoV-2 serology assays reveals a range of test performance(2020)297 cited
- → The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor(2010)265 cited
- → Test performance evaluation of SARS-CoV-2 serological assays(2020)253 cited
- → Memory T cell–driven differentiation of naive cells impairs adoptive immunotherapy(2015)245 cited
- → Developing neoantigen-targeted T cell–based treatments for solid tumors(2019)237 cited
- → Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy(2017)213 cited